PM360
FEBRUARY 1, 2024
The landscape is highly competitive with new prescription medications launching worldwide each year. Early shaping of the label during clinical trial design, risk mitigation, and avoiding approval delays are crucial for seizing a competitive advantage.
pharmaphorum
JANUARY 27, 2023
Demand has also increased due to changes in prescribing protocols, leading to a higher underlying number of prescriptions for certain antibiotic medicines. He previously held regional leadership roles at Sandoz between 2005 and 2010. The impact is two-fold.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
APRIL 18, 2024
RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end.
Evolve Your Success
MAY 16, 2023
I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. We’re in 2022 so a lot has happened since 2010. Years ago, doctors were writing prescriptions and lots of them were helping. It may be you go in and get a 30-day prescription. I came on board a few years ago.
Pharmaceutical Technology
OCTOBER 25, 2022
Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Of those 131 approved FDCs, 98 were oral dosage forms.
Pharmaceutical Technology
MAY 29, 2008
PT: How do you think GSK is placed competitively? Important elements within this expectation are the build up of strong contributions from Rotarix, Cervarix and Tykerb, while the outlook for GSK’s important asthma franchise becomes less clear beyond 2010. PD: We believe that GSK has the strongest pipeline in the industry.
Pharmaceutical Technology
JANUARY 6, 2023
The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.
Expert insights. Personalized for you.
59 
Let's personalize your content